PharmGen Science Inc (004720) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, PharmGen Science Inc (004720) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.91 Billion ≈ $1.29 Million USD) by net assets (₩247.76 Billion ≈ $167.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see PharmGen Science Inc (004720) total market value for the company's overall valuation and market capitalisation.

PharmGen Science Inc - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how PharmGen Science Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

PharmGen Science Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PharmGen Science Inc ranked by their cash flow conversion efficiency. Explore how high is PharmGen Science Inc's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Lustrum Minerals Limited AU:LRM	-0.285x
Mr Bricolage PA:ALMRB	-0.020x
Sand Nisko Capital Bhd KLSE:7943	-0.022x
AXIOS Sustainable Growth NYSE:AXAC	-0.003x
Skyline Builders Group Holding Limited NASDAQ:KAZR	-0.016x
Averbuch Formica Center Ltd TA:AVER	0.047x
Elastron S.A. - Steel Service Centers AT:ELSTR	-0.043x
Haesung Optics Co. Ltd KQ:076610	-0.009x

Annual Cash Flow Conversion Efficiency for PharmGen Science Inc (2011–2024)

The table below shows the annual cash flow conversion efficiency of PharmGen Science Inc from 2011 to 2024. View today's stock price for PharmGen Science Inc for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩249.43 Billion ≈ $169.03 Million	₩2.38 Billion ≈ $1.62 Million	0.010x	-59.89%
2023-12-31	₩228.21 Billion ≈ $154.66 Million	₩5.44 Billion ≈ $3.69 Million	0.024x	+483.79%
2022-12-31	₩207.12 Billion ≈ $140.36 Million	₩-1.29 Billion ≈ $-871.62K	-0.006x	-110.13%
2021-12-31	₩126.93 Billion ≈ $86.02 Million	₩7.78 Billion ≈ $5.28 Million	0.061x	+91.54%
2020-12-31	₩83.57 Billion ≈ $56.63 Million	₩2.68 Billion ≈ $1.81 Million	0.032x	-28.64%
2019-12-31	₩56.25 Billion ≈ $38.12 Million	₩2.52 Billion ≈ $1.71 Million	0.045x	-39.50%
2018-12-31	₩56.85 Billion ≈ $38.52 Million	₩4.22 Billion ≈ $2.86 Million	0.074x	+106.01%
2017-12-31	₩51.05 Billion ≈ $34.60 Million	₩1.84 Billion ≈ $1.25 Million	0.036x	-83.10%
2016-12-31	₩36.41 Billion ≈ $24.67 Million	₩7.75 Billion ≈ $5.26 Million	0.213x	+68.55%
2015-12-31	₩28.66 Billion ≈ $19.42 Million	₩3.62 Billion ≈ $2.45 Million	0.126x	+226.04%
2014-12-31	₩20.12 Billion ≈ $13.63 Million	₩-2.02 Billion ≈ $-1.37 Million	-0.100x	+43.17%
2013-12-31	₩23.83 Billion ≈ $16.15 Million	₩-4.20 Billion ≈ $-2.85 Million	-0.176x	-213.97%
2011-12-31	₩18.69 Billion ≈ $12.67 Million	₩2.89 Billion ≈ $1.96 Million	0.155x	--

About PharmGen Science Inc

KO:004720 Korea Drug Manufacturers - General

Market Cap

$42.84 Million

₩63.22 Billion KRW

Market Cap Rank

#22566 Global

#1454 in Korea

Share Price

₩2885.00

Change (1 day)

+0.00%

52-Week Range

₩2710.00 - ₩4590.00

All Time High

₩27300.00